• High Tide hemp-derived CBD unit NuLeaf Naturals plans to seek participation in CMS Innovation Center Beneficiary Engagement Incentive pilot that launched today.
• NuLeaf has begun outreach to eligible participants, including ACO REACH organizations and Enhancing Oncology Model oncology practices.
• Pilot allows participating providers to furnish eligible hemp-derived CBD products to Medicare beneficiaries at no cost, up to USD 500 per year per beneficiary.
• CMS indicated program could expand to Long-term Enhanced ACO Design model participants starting Jan. 1, 2027.
• High Tide positioned NuLeaf as supplier for physician-guided use cases, targeting growth in its US CBD business if adoption scales.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. High Tide Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001279569-26-000295), on April 14, 2026, and is solely responsible for the information contained therein.